Could an iron scavenger slow ALS? small study tests safety

NCT ID NCT02164253

First seen Feb 23, 2026 · Last updated May 17, 2026 · Updated 11 times

Summary

This study tested whether a drug called deferiprone, which removes excess iron from the body, is safe and can slow the progression of ALS (Lou Gehrig's disease). Researchers believe too much iron in the brain may damage nerve cells. Twenty-three adults with ALS took the drug for several months, and the study measured changes in their muscle function and overall ability to perform daily tasks. The goal was to see if reducing brain iron could help preserve movement and independence.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALS (AMYOTROPHIC LATERAL SCLEROSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hôpital Roger Salengro, CHRU de Lille

    Lille, 59000, France

Conditions

Explore the condition pages connected to this study.